Ticker > Company >

Wanbury share price

Wanbury Ltd.

NSE: WANBURY BSE: 524212 SECTOR: Pharmaceuticals & Drugs  21k   19   2

211.00
-11.00 (-4.95%)
BSE: Today, 03:11 PM

Price Summary

Today's High

₹ 222.45

Today's Low

₹ 211

52 Week High

₹ 291

52 Week Low

₹ 97.53

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

691.25 Cr.

Enterprise Value

795.3 Cr.

No. of Shares

3.28 Cr.

P/E

25.22

P/B

17.84

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  11.83

CASH

5.9 Cr.

DEBT

109.95 Cr.

Promoter Holding

39.77 %

EPS (TTM)

₹  8.37

Sales Growth

15.21%

ROE

502.76 %

ROCE

61.61%

Profit Growth

392.42 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year15.21%
3 Year13.61%
5 Year8.02%

Profit Growth

1 Year392.42%
3 Year64.01%
5 Year26.38%

ROE%

1 Year502.76%
3 Year167.59%
5 Year100.55%

ROCE %

1 Year61.61%
3 Year95.18%
5 Year103.74%

Debt/Equity

5.2108

Price to Cash Flow

172.08

Interest Cover Ratio

2.0548

CFO/PAT (5 Yr. Avg.)

0.816163527878013

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 39.77 76.74
Jun 2024 39.79 76.74
Mar 2024 39.79 71.05
Dec 2023 39.79 76.74
Sep 2023 39.80 76.74
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 64.0077304360772% for the Past 3 years.
  • Company has been maintaining healthy ROE of 167.585933333333% over the past 3 years.
  • Company has been maintaining healthy ROCE of 95.182970832159% over the past 3 years.
  • Company’s PEG ratio is 0.0643365339959617.
  • The company has an efficient Cash Conversion Cycle of -119.5122 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 32.2050306774782.

 Limitations

  • The company has shown a poor revenue growth of 13.6141945309408% for the Past 3 years.
  • Company has high Debt to Equity ratio of 5.2108.
  • Company has contingent liabilities of 60.0385 Cr.
  • Tax rate is low at 1.2378.
  • Promoter pledging is high as 76.74%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 144.46 145.5 139.41 131.11 161.19
Total Expenditure 127.12 124.35 121.24 120.13 141.18
Operating Profit 17.34 21.15 18.16 10.97 20.01
Other Income 0.76 0.69 0.93 0.95 1.63
Interest 7.67 8.26 7.46 7.59 10.15
Depreciation 3.24 3.32 3.28 3.29 3.32
Exceptional Items 0 0 0 0 0
Profit Before Tax 7.19 10.26 8.35 1.04 8.17
Tax -0.18 -0.02 0.27 0 0.15
Profit After Tax 7.36 10.27 8.08 1.04 8.02
Adjusted EPS (Rs) 2.25 3.14 2.47 0.32 2.45

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 367.45 392.52 511.19 499.65 575.65
Total Expenditure 389.07 376.85 479.45 476.57 505.65
Operating Profit -21.62 15.67 31.73 23.08 70
Other Income 46.2 4.75 5.09 1.01 2.99
Interest 32.87 23.07 20.61 21.39 29.18
Depreciation 9.68 9.75 11.45 12.38 13.03
Exceptional Items 82.64 0 76.37 -0.59 0
Profit Before Tax 64.67 -12.41 81.13 -10.29 30.78
Tax 0.21 0.2 -0.35 0.11 0.38
Net Profit 64.46 -12.61 81.47 -10.4 30.4
Adjusted EPS (Rs.) 25.79 -5.04 24.94 -3.18 9.28

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 25 25.02 32.67 32.71 32.75
Total Reserves -142.83 -155.67 -30.48 -39.96 -4.8
Borrowings 99.54 71.99 0 0 82
Other N/C liabilities 8.2 12.44 10.56 10.81 13.95
Current liabilities 283.89 328.19 332.62 292.84 214.11
Total Liabilities 273.8 281.97 345.37 296.4 337.99
Assets
Net Block 163.9 167.38 167.11 167.11 166.82
Capital WIP 13.89 11.01 2.35 1.61 3.01
Intangible WIP 0 0 0 0 0
Investments 0.01 0.01 0.01 0.01 0.03
Loans & Advances 3.8 3.4 3.8 5.03 5.42
Other N/C Assets 0.1 4.2 2.41 2.46 3.44
Current Assets 92.11 95.95 169.69 120.19 159.29
Total Assets 273.8 281.97 345.37 296.4 337.99
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 64.67 -12.41 81.13 -10.29 30.78
Adjustment -41.41 33.22 -43.68 37.01 41.61
Changes in Assets & Liabilities 20.9 -3 3.24 -6.75 -68.19
Tax Paid -0.03 -1.13 -0.16 -0.17 -0.18
Operating Cash Flow 44.13 16.68 40.52 19.8 4.02
Investing Cash Flow 63.66 8.04 0.59 -8.84 -16.63
Financing Cash Flow -107.87 -17.39 -28.58 -31.99 14.55
Net Cash Flow -0.09 7.34 12.53 -21.03 1.94

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 39.80 39.79 39.79 39.79 39.77
expert chemicals (india) ... 30.56 30.56 30.56 30.56 30.54
kingsbury investments inc... 9.24 9.23 9.23 9.23 9.23
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 60.20 60.21 60.21 60.21 60.23
authum investment and inf... 3.86 3.86 2.35 2.35 2.34
east eight six advisors l... 1.41 1.41 1.41 1.41 1.38
investor education and pr... 1.03 1.03 1.03 1.03 1.03
llp 1.45 1.55 1.53 1.55 1.62
magnum equifin private li... 1.53 1.53 1.53 1.53 1.53
milan manharkant ganatra 1.08 1.08 1.08 1.08 1.05
surbhi investments and tr... - - - 1.72 1.68
suresh bhatia 2.35 2.35 2.20 2.20 2.20
elizabeth mathew - - - 1.13 -
elizabeth mathew . - 4.59 1.13 - -
varalakshmi veldi . 1.41 1.41 1.21 - -
vijay k choraria 2.82 2.82 2.29 - -
yanni global (opc) privat... 1.30 1.30 1.05 - -
bakliwal fincom private l... 2.82 2.82 - - -
elizabeth mathew 5.64 - - - -

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Wanbury informs about press release 9 Sep, 9:38 AM Wanbury gets CEP for Dextromethorphan active pharmaceutical ingredient 9 Sep, 9:37 AM Wanbury informs about press release 23 Aug, 10:17 AM Wanbury gets EIR from USFDA for Maharashtra manufacturing facility 23 Aug, 10:12 AM Wanbury informs about updates 21 Aug, 3:12 PM Wanbury - Quaterly Results 12 Aug, 9:46 PM Wanbury - Quaterly Results 12 Aug, 9:46 PM Wanbury receives term loan facilities of Rs 60 crore from Tata Capital 27 Jun, 4:16 PM Wanbury informs about US FDA inspection 18 Jun, 2:18 PM USFDA completes inspection at Wanbury’s Patalganga site 18 Jun, 10:41 AM Wanbury - Quaterly Results 16 May, 7:26 PM Wanbury - Quaterly Results 16 May, 7:26 PM Wanbury informs about board meeting 7 May, 5:23 PM Wanbury informs about certificate 4 Apr, 5:24 PM Wanbury informs about completion of tenure of independent director 21 Feb, 2:10 PM Wanbury informs about press release 25 Jan, 5:16 PM Wanbury - Quaterly Results 24 Jan, 3:57 PM Wanbury - Quaterly Results 24 Jan, 3:57 PM Wanbury - Quaterly Results 24 Jan, 3:57 PM Wanbury informs about updates 15 Dec, 3:41 PM Wanbury informs about change in management 18 Nov, 3:46 PM Wanbury - Quaterly Results 20 Oct, 7:28 PM Wanbury - Quaterly Results 20 Oct, 7:28 PM Wanbury - Quaterly Results 7 Jul, 7:37 PM Wanbury - Quaterly Results 7 Jul, 7:37 PM Wanbury informs about closure of trading window 30 Dec, 5:07 PM Wanbury - Quaterly Results 28 Nov, 6:09 PM Wanbury - Quaterly Results 28 Nov, 6:09 PM Wanbury - Quaterly Results 28 Nov, 6:09 PM Wanbury - Quaterly Results 22 Jun, 7:17 PM Wanbury - Quaterly Results 22 Jun, 7:17 PM Wanbury - Quaterly Results 8 Feb, 4:13 PM Wanbury - Quaterly Results 8 Feb, 4:13 PM Wanbury - Quaterly Results 8 Feb, 4:13 PM Wanbury informs about closure of trading window 31 Dec, 2:00 PM Wanbury - Quaterly Results 25 Nov, 3:14 PM Wanbury - Quaterly Results 25 Nov, 3:14 PM Wanbury - Quaterly Results 25 Nov, 3:14 PM Wanbury - Quaterly Results 20 Oct, 3:06 PM Wanbury informs about annual secretarial compliance report 29 Jun, 3:22 PM Wanbury informs about disclosure 27 Apr, 9:54 AM Wanbury informs about outcome of EGM 20 Mar, 3:40 PM

Wanbury Stock Price Analysis and Quick Research Report. Is Wanbury an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Wanbury and its performance over the period of time. Wanbury stock price today is Rs 213.31.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Wanbury cash from the operating activity was Rs 4.0169 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Wanbury has a Debt to Equity ratio of 5.2108 , which is a weak indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Wanbury , the EPS growth was 392.0657 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Wanbury has OPM of 12.1605531696528 % which is a bad sign for profitability.
     
  • ROE: Wanbury have a healthy ROE of 502.7578 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Wanbury is Rs 213.31. One can use valuation calculators of ticker to know if Wanbury share price is undervalued or overvalued.
Last Updated on:
Brief about Wanbury
X